(Reuters) -Indian pharmaceutical stocks fell 1.7% on Wednesday after U.S. President Donald Trump reiterated plans to announce ...

Ironwood Pharmaceuticals shares sank after the company said it needs to conduct a confirmatory phase 3 trial of proposed short-bowel treatment apraglutide. The stock hit a 52-week low in mid-morning ...

US drugmakers' shares drop 3% to 6% premarket European, Indian healthcare stocks drag down broader indexes Trump aims to shift pharma manufacturing to US, but analysts doubtful April 9 (Reuters ...

Trump on Tuesday said his administration will be announcing a “major” tariff on pharmaceuticals “very shortly.” ...

CHENNAI: Indian pharmaceutical stocks experienced a significant drop on Friday, with the Nifty Pharma Index falling 4.4%, ...

US President Donald Trump, speaking at an event at the National Republican Congressional Committee, said the tariff will ...

Indian pharmaceutical companies are crucial to the U.S. healthcare system, filling four out of every ten prescriptions in ...

Pharmaceutical stocks fell across Asian markets after U.S. President Trump said he plans to impose a "major" tariff on all pharmaceutical imports.

European healthcare stocks tumble as Trump prepares new tariffs, with pharmaceutical firms bracing for economic fallout and market uncertainty.

Drugmakers' stocks in Europe and India slipped on Wednesday after U.S. President Donald Trump reiterated plans for a "major" ...

"We have to do, we're going to put we're going to tariff our pharmaceuticals. And once we do that, they're going to come rushing back into our country because we are the big market, the advantage ...